samedan logo
 
 
spacer
home > epc > summer 2007 > symmetrical data management
PUBLICATIONS
European Pharmaceutical Contractor

Symmetrical Data Management

Sheila Kelly at ICON Clinical Research examines the development of data management metrics for practical use within the pharmaceutical industry

“Businesses that succeed constantly assess themselves and improve in all dimensions of their business; metrics are the cornerstone of their assessment, and the foundation for any business improvement” (1). Within the pharmaceutical industry huge emphasis is placed on cost containment of clinical trials. There is a growing trend that encourages us to scruntinise each project task with a view to reducing costs. This is particularly evident for support services, such as data processing; contract research organisations (CROs) are driven to provide robust resource plans and budgets that accurately reflect the project’s activities.

THE PROJECT PLAN

The successful project plan has four successive stages – initiation, set-up, maintenance and closeout. In stage one, the scope of the project is defined by identifying the main aims; stage two underpins the resources required to perform these tasks and the associated costs; stage three progresses to project implementation and fulfilment of the original goals outlined in stage one, and stage four is the evaluation period when corrective measures are put in place and lessons learned are carried forward to the next project (see Figure 1a). All of these stages are interdependent and in ideal conditions rely upon having the correct information to hand at each stage of the project’s development in order to advance to the next stage.

However, when we apply this model at the initiation stage of an actual project, we are often forced to jump back and forth between project stages. Frequently the project manager or contract analyst is requested to assign resource and develop the project budget in the absence of the full knowledge of the sponsor’s goals and objectives that should have been completed at stage one. The project frequently begins at stage two (see Figure 1b), where there is an emphasis on cost development and resource allocation. In an effort to keep the project plan intact, the experienced contract analyst will compile available information from all sources, such as information on previous studies taken from the in-house project database, and will solicit input from therapeutic and technology experts.

All stages of the project are interdependent: no one stage of the project is finished until the project is complete in its entirety. For example, stage two of the project management plan may be revisited throughout the project’s lifecycle to adjust resource and costs in order to reflect changes in the project specifications.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sheila Kelly, Senior Manager of Business Development Services, has worked with ICON Clinical Research since 1999. Sheila has 11 years’ business development experience in various industries and has spent eight years working with the pharmaceutical industry, mainly in data management with a focus on budget development and vendor management. She was obtained her BA at University College, Dublin, and completed postgraduate work at Griffith College, Dublin.
spacer
Sheila Kelly
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement